nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitisinone—HPD—gonad—ovarian cancer	0.0737	0.383	CbGeAlD
Nitisinone—HPD—female reproductive system—ovarian cancer	0.0658	0.342	CbGeAlD
Nitisinone—HPD—testis—ovarian cancer	0.0531	0.276	CbGeAlD
Nitisinone—Septicemia—Vinorelbine—ovarian cancer	0.0376	0.0484	CcSEcCtD
Nitisinone—Neoplasm malignant—Altretamine—ovarian cancer	0.0369	0.0475	CcSEcCtD
Nitisinone—Flutamide—CYP1B1—ovarian cancer	0.03	1	CrCbGaD
Nitisinone—Septicemia—Epirubicin—ovarian cancer	0.0145	0.0186	CcSEcCtD
Nitisinone—Septicemia—Doxorubicin—ovarian cancer	0.0134	0.0172	CcSEcCtD
Nitisinone—Neoplasm malignant—Chlorambucil—ovarian cancer	0.0131	0.0169	CcSEcCtD
Nitisinone—Rash erythematous—Topotecan—ovarian cancer	0.013	0.0168	CcSEcCtD
Nitisinone—Amenorrhoea—Chlorambucil—ovarian cancer	0.0128	0.0164	CcSEcCtD
Nitisinone—Leukopenia—Altretamine—ovarian cancer	0.0123	0.0159	CcSEcCtD
Nitisinone—Convulsion—Altretamine—ovarian cancer	0.012	0.0154	CcSEcCtD
Nitisinone—Neoplasm malignant—Melphalan—ovarian cancer	0.0114	0.0147	CcSEcCtD
Nitisinone—Amenorrhoea—Melphalan—ovarian cancer	0.0111	0.0143	CcSEcCtD
Nitisinone—Thrombocytopenia—Altretamine—ovarian cancer	0.011	0.0142	CcSEcCtD
Nitisinone—Respiratory failure—Topotecan—ovarian cancer	0.0102	0.0131	CcSEcCtD
Nitisinone—Rash maculo-papular—Topotecan—ovarian cancer	0.00907	0.0117	CcSEcCtD
Nitisinone—Encephalopathy—Paclitaxel—ovarian cancer	0.00895	0.0115	CcSEcCtD
Nitisinone—Keratitis—Paclitaxel—ovarian cancer	0.00886	0.0114	CcSEcCtD
Nitisinone—Respiratory failure—Vinorelbine—ovarian cancer	0.0087	0.0112	CcSEcCtD
Nitisinone—Sepsis—Topotecan—ovarian cancer	0.00866	0.0111	CcSEcCtD
Nitisinone—Hepatomegaly—Paclitaxel—ovarian cancer	0.00812	0.0104	CcSEcCtD
Nitisinone—Infection—Carboplatin—ovarian cancer	0.00773	0.00994	CcSEcCtD
Nitisinone—Rash erythematous—Paclitaxel—ovarian cancer	0.0075	0.00965	CcSEcCtD
Nitisinone—Sepsis—Vinorelbine—ovarian cancer	0.00741	0.00953	CcSEcCtD
Nitisinone—Hepatic failure—Vinorelbine—ovarian cancer	0.0069	0.00887	CcSEcCtD
Nitisinone—Rash erythematous—Docetaxel—ovarian cancer	0.00636	0.00818	CcSEcCtD
Nitisinone—Respiratory failure—Paclitaxel—ovarian cancer	0.00585	0.00752	CcSEcCtD
Nitisinone—Melaena—Paclitaxel—ovarian cancer	0.00561	0.00722	CcSEcCtD
Nitisinone—Amenorrhoea—Docetaxel—ovarian cancer	0.00554	0.00713	CcSEcCtD
Nitisinone—Epistaxis—Topotecan—ovarian cancer	0.00527	0.00678	CcSEcCtD
Nitisinone—Rash maculo-papular—Paclitaxel—ovarian cancer	0.00522	0.00672	CcSEcCtD
Nitisinone—Keratitis—Epirubicin—ovarian cancer	0.00506	0.00651	CcSEcCtD
Nitisinone—Haemoglobin—Topotecan—ovarian cancer	0.00504	0.00648	CcSEcCtD
Nitisinone—Haemorrhage—Topotecan—ovarian cancer	0.00501	0.00645	CcSEcCtD
Nitisinone—Sepsis—Paclitaxel—ovarian cancer	0.00498	0.00641	CcSEcCtD
Nitisinone—Alopecia—Chlorambucil—ovarian cancer	0.00498	0.0064	CcSEcCtD
Nitisinone—Respiratory failure—Docetaxel—ovarian cancer	0.00496	0.00638	CcSEcCtD
Nitisinone—Haemoglobin—Melphalan—ovarian cancer	0.00493	0.00635	CcSEcCtD
Nitisinone—Haemorrhage—Melphalan—ovarian cancer	0.00491	0.00631	CcSEcCtD
Nitisinone—Keratitis—Doxorubicin—ovarian cancer	0.00468	0.00603	CcSEcCtD
Nitisinone—Hepatomegaly—Epirubicin—ovarian cancer	0.00464	0.00597	CcSEcCtD
Nitisinone—Eye pain—Paclitaxel—ovarian cancer	0.00462	0.00594	CcSEcCtD
Nitisinone—Agitation—Chlorambucil—ovarian cancer	0.0045	0.00579	CcSEcCtD
Nitisinone—Agranulocytosis—Vinorelbine—ovarian cancer	0.00446	0.00573	CcSEcCtD
Nitisinone—Alopecia—Topotecan—ovarian cancer	0.00443	0.0057	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00442	0.00568	CcSEcCtD
Nitisinone—Leukopenia—Chlorambucil—ovarian cancer	0.00439	0.00564	CcSEcCtD
Nitisinone—Alopecia—Melphalan—ovarian cancer	0.00434	0.00558	CcSEcCtD
Nitisinone—Hepatomegaly—Doxorubicin—ovarian cancer	0.00429	0.00552	CcSEcCtD
Nitisinone—Rash erythematous—Epirubicin—ovarian cancer	0.00429	0.00552	CcSEcCtD
Nitisinone—Hypoglycaemia—Paclitaxel—ovarian cancer	0.00427	0.0055	CcSEcCtD
Nitisinone—Convulsion—Chlorambucil—ovarian cancer	0.00425	0.00546	CcSEcCtD
Nitisinone—Sepsis—Docetaxel—ovarian cancer	0.00422	0.00543	CcSEcCtD
Nitisinone—Infection—Chlorambucil—ovarian cancer	0.00397	0.00511	CcSEcCtD
Nitisinone—Rash erythematous—Doxorubicin—ovarian cancer	0.00397	0.0051	CcSEcCtD
Nitisinone—Hepatic failure—Docetaxel—ovarian cancer	0.00393	0.00506	CcSEcCtD
Nitisinone—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00392	0.00504	CcSEcCtD
Nitisinone—Leukopenia—Topotecan—ovarian cancer	0.00391	0.00502	CcSEcCtD
Nitisinone—Dehydration—Paclitaxel—ovarian cancer	0.00388	0.00499	CcSEcCtD
Nitisinone—Neoplasm malignant—Epirubicin—ovarian cancer	0.00385	0.00495	CcSEcCtD
Nitisinone—Leukopenia—Melphalan—ovarian cancer	0.00382	0.00492	CcSEcCtD
Nitisinone—Dry skin—Paclitaxel—ovarian cancer	0.00382	0.00492	CcSEcCtD
Nitisinone—Alopecia—Vinorelbine—ovarian cancer	0.00379	0.00487	CcSEcCtD
Nitisinone—Amenorrhoea—Epirubicin—ovarian cancer	0.00374	0.00481	CcSEcCtD
Nitisinone—Convulsion—Melphalan—ovarian cancer	0.0037	0.00476	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00369	0.00475	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00361	0.00465	CcSEcCtD
Nitisinone—Neoplasm malignant—Doxorubicin—ovarian cancer	0.00356	0.00458	CcSEcCtD
Nitisinone—Infection—Topotecan—ovarian cancer	0.00354	0.00455	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.00353	0.00455	CcSEcCtD
Nitisinone—Thrombocytopenia—Topotecan—ovarian cancer	0.00349	0.00449	CcSEcCtD
Nitisinone—Bronchitis—Paclitaxel—ovarian cancer	0.00347	0.00446	CcSEcCtD
Nitisinone—Infection—Melphalan—ovarian cancer	0.00346	0.00446	CcSEcCtD
Nitisinone—Skin disorder—Topotecan—ovarian cancer	0.00346	0.00445	CcSEcCtD
Nitisinone—Amenorrhoea—Doxorubicin—ovarian cancer	0.00346	0.00445	CcSEcCtD
Nitisinone—Thrombocytopenia—Melphalan—ovarian cancer	0.00341	0.00439	CcSEcCtD
Nitisinone—Skin disorder—Melphalan—ovarian cancer	0.00339	0.00436	CcSEcCtD
Nitisinone—Leukopenia—Vinorelbine—ovarian cancer	0.00334	0.0043	CcSEcCtD
Nitisinone—Dehydration—Docetaxel—ovarian cancer	0.00329	0.00423	CcSEcCtD
Nitisinone—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00327	0.00421	CcSEcCtD
Nitisinone—Dry skin—Docetaxel—ovarian cancer	0.00324	0.00417	CcSEcCtD
Nitisinone—Melaena—Epirubicin—ovarian cancer	0.00321	0.00413	CcSEcCtD
Nitisinone—Abdominal pain—Chlorambucil—ovarian cancer	0.00316	0.00407	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00316	0.00406	CcSEcCtD
Nitisinone—Conjunctivitis—Paclitaxel—ovarian cancer	0.00312	0.00402	CcSEcCtD
Nitisinone—Epistaxis—Paclitaxel—ovarian cancer	0.00303	0.0039	CcSEcCtD
Nitisinone—Infection—Vinorelbine—ovarian cancer	0.00303	0.00389	CcSEcCtD
Nitisinone—Rash maculo-papular—Epirubicin—ovarian cancer	0.00298	0.00384	CcSEcCtD
Nitisinone—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00298	0.00384	CcSEcCtD
Nitisinone—Melaena—Doxorubicin—ovarian cancer	0.00297	0.00382	CcSEcCtD
Nitisinone—Skin disorder—Vinorelbine—ovarian cancer	0.00296	0.00381	CcSEcCtD
Nitisinone—Gastrointestinal pain—Topotecan—ovarian cancer	0.00291	0.00375	CcSEcCtD
Nitisinone—Haemoglobin—Paclitaxel—ovarian cancer	0.0029	0.00373	CcSEcCtD
Nitisinone—Haemorrhage—Paclitaxel—ovarian cancer	0.00288	0.00371	CcSEcCtD
Nitisinone—Sepsis—Epirubicin—ovarian cancer	0.00285	0.00367	CcSEcCtD
Nitisinone—Pruritus—Chlorambucil—ovarian cancer	0.00283	0.00364	CcSEcCtD
Nitisinone—Abdominal pain—Topotecan—ovarian cancer	0.00282	0.00362	CcSEcCtD
Nitisinone—Rash maculo-papular—Doxorubicin—ovarian cancer	0.00276	0.00355	CcSEcCtD
Nitisinone—Diarrhoea—Chlorambucil—ovarian cancer	0.00274	0.00352	CcSEcCtD
Nitisinone—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00273	0.00351	CcSEcCtD
Nitisinone—Eye disorder—Paclitaxel—ovarian cancer	0.0027	0.00347	CcSEcCtD
Nitisinone—Hepatic failure—Epirubicin—ovarian cancer	0.00265	0.00341	CcSEcCtD
Nitisinone—Conjunctivitis—Docetaxel—ovarian cancer	0.00265	0.00341	CcSEcCtD
Nitisinone—Eye pain—Epirubicin—ovarian cancer	0.00264	0.0034	CcSEcCtD
Nitisinone—Sepsis—Doxorubicin—ovarian cancer	0.00264	0.00339	CcSEcCtD
Nitisinone—Epistaxis—Docetaxel—ovarian cancer	0.00257	0.0033	CcSEcCtD
Nitisinone—Alopecia—Paclitaxel—ovarian cancer	0.00255	0.00328	CcSEcCtD
Nitisinone—Agranulocytosis—Docetaxel—ovarian cancer	0.00254	0.00327	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00253	0.00325	CcSEcCtD
Nitisinone—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00252	0.00325	CcSEcCtD
Nitisinone—Pruritus—Topotecan—ovarian cancer	0.00252	0.00324	CcSEcCtD
Nitisinone—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00249	0.0032	CcSEcCtD
Nitisinone—Pruritus—Melphalan—ovarian cancer	0.00247	0.00317	CcSEcCtD
Nitisinone—Tension—Paclitaxel—ovarian cancer	0.00246	0.00317	CcSEcCtD
Nitisinone—Haemoglobin—Docetaxel—ovarian cancer	0.00246	0.00316	CcSEcCtD
Nitisinone—Hepatic failure—Doxorubicin—ovarian cancer	0.00245	0.00316	CcSEcCtD
Nitisinone—Haemorrhage—Docetaxel—ovarian cancer	0.00244	0.00314	CcSEcCtD
Nitisinone—Eye pain—Doxorubicin—ovarian cancer	0.00244	0.00314	CcSEcCtD
Nitisinone—Hypoglycaemia—Epirubicin—ovarian cancer	0.00244	0.00314	CcSEcCtD
Nitisinone—Nervousness—Paclitaxel—ovarian cancer	0.00244	0.00314	CcSEcCtD
Nitisinone—Diarrhoea—Topotecan—ovarian cancer	0.00244	0.00313	CcSEcCtD
Nitisinone—Abdominal pain—Vinorelbine—ovarian cancer	0.00241	0.0031	CcSEcCtD
Nitisinone—Diarrhoea—Melphalan—ovarian cancer	0.00239	0.00307	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.00238	0.00307	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00234	0.00301	CcSEcCtD
Nitisinone—Agitation—Paclitaxel—ovarian cancer	0.00231	0.00297	CcSEcCtD
Nitisinone—Eye disorder—Docetaxel—ovarian cancer	0.00228	0.00294	CcSEcCtD
Nitisinone—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00226	0.00291	CcSEcCtD
Nitisinone—Leukopenia—Paclitaxel—ovarian cancer	0.00225	0.00289	CcSEcCtD
Nitisinone—Headache—Topotecan—ovarian cancer	0.00223	0.00287	CcSEcCtD
Nitisinone—Dehydration—Epirubicin—ovarian cancer	0.00222	0.00285	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.00221	0.00284	CcSEcCtD
Nitisinone—Dry skin—Epirubicin—ovarian cancer	0.00218	0.00281	CcSEcCtD
Nitisinone—Convulsion—Paclitaxel—ovarian cancer	0.00218	0.0028	CcSEcCtD
Nitisinone—Alopecia—Docetaxel—ovarian cancer	0.00216	0.00278	CcSEcCtD
Nitisinone—Pruritus—Vinorelbine—ovarian cancer	0.00216	0.00277	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00212	0.00273	CcSEcCtD
Nitisinone—Gastritis—Epirubicin—ovarian cancer	0.00211	0.00271	CcSEcCtD
Nitisinone—Diarrhoea—Vinorelbine—ovarian cancer	0.00208	0.00268	CcSEcCtD
Nitisinone—Dehydration—Doxorubicin—ovarian cancer	0.00205	0.00264	CcSEcCtD
Nitisinone—Infection—Paclitaxel—ovarian cancer	0.00204	0.00262	CcSEcCtD
Nitisinone—Dry skin—Doxorubicin—ovarian cancer	0.00202	0.0026	CcSEcCtD
Nitisinone—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00201	0.00258	CcSEcCtD
Nitisinone—Skin disorder—Paclitaxel—ovarian cancer	0.00199	0.00256	CcSEcCtD
Nitisinone—Bronchitis—Epirubicin—ovarian cancer	0.00198	0.00255	CcSEcCtD
Nitisinone—Gastritis—Doxorubicin—ovarian cancer	0.00195	0.00251	CcSEcCtD
Nitisinone—Headache—Vinorelbine—ovarian cancer	0.00191	0.00246	CcSEcCtD
Nitisinone—Leukopenia—Docetaxel—ovarian cancer	0.00191	0.00245	CcSEcCtD
Nitisinone—Convulsion—Docetaxel—ovarian cancer	0.00184	0.00237	CcSEcCtD
Nitisinone—Bronchitis—Doxorubicin—ovarian cancer	0.00183	0.00236	CcSEcCtD
Nitisinone—Somnolence—Paclitaxel—ovarian cancer	0.00182	0.00234	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.0018	0.00231	CcSEcCtD
Nitisinone—Conjunctivitis—Epirubicin—ovarian cancer	0.00179	0.0023	CcSEcCtD
Nitisinone—Epistaxis—Epirubicin—ovarian cancer	0.00173	0.00223	CcSEcCtD
Nitisinone—Infection—Docetaxel—ovarian cancer	0.00173	0.00222	CcSEcCtD
Nitisinone—Agranulocytosis—Epirubicin—ovarian cancer	0.00171	0.00221	CcSEcCtD
Nitisinone—Thrombocytopenia—Docetaxel—ovarian cancer	0.0017	0.00219	CcSEcCtD
Nitisinone—Skin disorder—Docetaxel—ovarian cancer	0.00169	0.00217	CcSEcCtD
Nitisinone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00168	0.00216	CcSEcCtD
Nitisinone—Haemoglobin—Epirubicin—ovarian cancer	0.00166	0.00213	CcSEcCtD
Nitisinone—Conjunctivitis—Doxorubicin—ovarian cancer	0.00165	0.00213	CcSEcCtD
Nitisinone—Haemorrhage—Epirubicin—ovarian cancer	0.00165	0.00212	CcSEcCtD
Nitisinone—Abdominal pain—Paclitaxel—ovarian cancer	0.00162	0.00208	CcSEcCtD
Nitisinone—Epistaxis—Doxorubicin—ovarian cancer	0.0016	0.00206	CcSEcCtD
Nitisinone—Agranulocytosis—Doxorubicin—ovarian cancer	0.00159	0.00204	CcSEcCtD
Nitisinone—Somnolence—Docetaxel—ovarian cancer	0.00154	0.00199	CcSEcCtD
Nitisinone—Eye disorder—Epirubicin—ovarian cancer	0.00154	0.00198	CcSEcCtD
Nitisinone—Haemoglobin—Doxorubicin—ovarian cancer	0.00153	0.00197	CcSEcCtD
Nitisinone—Haemorrhage—Doxorubicin—ovarian cancer	0.00153	0.00196	CcSEcCtD
Nitisinone—Alopecia—Epirubicin—ovarian cancer	0.00146	0.00187	CcSEcCtD
Nitisinone—Pruritus—Paclitaxel—ovarian cancer	0.00145	0.00186	CcSEcCtD
Nitisinone—Eye disorder—Doxorubicin—ovarian cancer	0.00143	0.00183	CcSEcCtD
Nitisinone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00142	0.00183	CcSEcCtD
Nitisinone—Tension—Epirubicin—ovarian cancer	0.00141	0.00181	CcSEcCtD
Nitisinone—Diarrhoea—Paclitaxel—ovarian cancer	0.0014	0.0018	CcSEcCtD
Nitisinone—Nervousness—Epirubicin—ovarian cancer	0.00139	0.00179	CcSEcCtD
Nitisinone—Abdominal pain—Docetaxel—ovarian cancer	0.00137	0.00177	CcSEcCtD
Nitisinone—Alopecia—Doxorubicin—ovarian cancer	0.00135	0.00173	CcSEcCtD
Nitisinone—Agitation—Epirubicin—ovarian cancer	0.00132	0.0017	CcSEcCtD
Nitisinone—Tension—Doxorubicin—ovarian cancer	0.0013	0.00168	CcSEcCtD
Nitisinone—Nervousness—Doxorubicin—ovarian cancer	0.00129	0.00166	CcSEcCtD
Nitisinone—Leukopenia—Epirubicin—ovarian cancer	0.00128	0.00165	CcSEcCtD
Nitisinone—Headache—Paclitaxel—ovarian cancer	0.00128	0.00165	CcSEcCtD
Nitisinone—Convulsion—Epirubicin—ovarian cancer	0.00124	0.0016	CcSEcCtD
Nitisinone—Pruritus—Docetaxel—ovarian cancer	0.00123	0.00158	CcSEcCtD
Nitisinone—Agitation—Doxorubicin—ovarian cancer	0.00122	0.00157	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00121	0.00156	CcSEcCtD
Nitisinone—Leukopenia—Doxorubicin—ovarian cancer	0.00119	0.00153	CcSEcCtD
Nitisinone—Diarrhoea—Docetaxel—ovarian cancer	0.00119	0.00153	CcSEcCtD
Nitisinone—Infection—Epirubicin—ovarian cancer	0.00116	0.0015	CcSEcCtD
Nitisinone—Convulsion—Doxorubicin—ovarian cancer	0.00115	0.00148	CcSEcCtD
Nitisinone—Thrombocytopenia—Epirubicin—ovarian cancer	0.00115	0.00148	CcSEcCtD
Nitisinone—Skin disorder—Epirubicin—ovarian cancer	0.00114	0.00146	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00112	0.00144	CcSEcCtD
Nitisinone—Headache—Docetaxel—ovarian cancer	0.00109	0.0014	CcSEcCtD
Nitisinone—Infection—Doxorubicin—ovarian cancer	0.00108	0.00139	CcSEcCtD
Nitisinone—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00106	0.00137	CcSEcCtD
Nitisinone—Skin disorder—Doxorubicin—ovarian cancer	0.00105	0.00135	CcSEcCtD
Nitisinone—Somnolence—Epirubicin—ovarian cancer	0.00104	0.00134	CcSEcCtD
Nitisinone—Somnolence—Doxorubicin—ovarian cancer	0.000964	0.00124	CcSEcCtD
Nitisinone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000958	0.00123	CcSEcCtD
Nitisinone—Abdominal pain—Epirubicin—ovarian cancer	0.000926	0.00119	CcSEcCtD
Nitisinone—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000886	0.00114	CcSEcCtD
Nitisinone—Abdominal pain—Doxorubicin—ovarian cancer	0.000857	0.0011	CcSEcCtD
Nitisinone—Pruritus—Epirubicin—ovarian cancer	0.000829	0.00107	CcSEcCtD
Nitisinone—Diarrhoea—Epirubicin—ovarian cancer	0.000802	0.00103	CcSEcCtD
Nitisinone—Pruritus—Doxorubicin—ovarian cancer	0.000767	0.000987	CcSEcCtD
Nitisinone—Diarrhoea—Doxorubicin—ovarian cancer	0.000742	0.000954	CcSEcCtD
Nitisinone—Headache—Epirubicin—ovarian cancer	0.000734	0.000944	CcSEcCtD
Nitisinone—Headache—Doxorubicin—ovarian cancer	0.000679	0.000874	CcSEcCtD
